Although there have been major therapeutic advancements in pediatric cancer care over the last several decades, cancer remains one of the most common causes of childhood death. In 1994, my nephew Andrew was diagnosed with rhabdomyosarcoma, a rare form of muscle tumor. Despite aggressive treatment at Dana-Farber, he passed away shortly before his third birthday.
With the generous support of family and friends, the Medicinal Chemistry Group of the Northeastern Section of the American Chemical Society and the Dana-Farber Cancer Institute, a fund was created in 1995 and endowed in 2001. The Andrew H. Weinberg Memorial Endowment Fund supports an annual Symposium that brings researchers together from the field of chemotherapy development with those in the biomedical research and clinical care communities at large, helping to foster an environment for synergy and originality in cancer research.
This year’s 24th Annual Andrew H. Weinberg Memorial Lecture has again been postponed due to covid-19, but we continue to fundraise for future years. When it is safe to resume our lectureship, we will be delighted to welcome Dr. Julie R. Park from Seattle Children’s Hospital to give a lecture on her immunotherapy work on solid tumors.
The symposium is primarily funded through Jimmy Fund Walk donations dedicated to Team Andrew Weinberg. Since 1994, a committed group has together walked thousands of miles in support of this symposium and to symbolically march in the battle against childhood cancer. To ensure this important annual event continues, Team Andrew Weinberg seeks your financial support.
Due to covid-19, these are hard times for all, including researchers in pediatric oncology. Please consider making a donation to our Team’s efforts. Your generosity is sincerely and deeply appreciated far beyond mere words, written or spoken.